Early Nasopharyngeal Cancer Screening - Epstein-Barr Virus (EBV) DNA Quantitative PCR for Nasopharyngeal Carcinoma
A quantitative PCR test detecting Epstein-Barr Virus genetic material in blood. It serves as a vital diagnostic and monitoring tool for Nasopharyngeal Carcinoma (NPC) to evaluate treatment efficacy.